IL-1 inhibitors
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IL-1 inhibitors, covering 2026-02-02 to 2026-02-02. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus Erythematosus [Phase 4]